Metric Finance
LearnFAQ
LearnFAQ

Learn / FENC

NASDAQ: FENC

Fennec Pharmaceuticals (FENC) stock, explained like you're 5

Fennec Pharmaceuticals trades on the Nasdaq under the ticker FENC. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 375 million dollars.

Ticker
FENC
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 375 million dollars

Is Fennec Pharmaceuticals a small, medium or large cap company?

No. Fennec Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 375 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Fennec Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves FENC stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • (FENC) Movement Within Algorithmic Entry Frameworks (Stock Traders Daily)
  • Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views (Yahoo Finance)
  • FENC Forecast Price Target Prediction for 2027 (TradingView)
  • Medical chief acquires 168 awarded shares at Fennec Pharmaceuticals (FENC), holding 9,687 directly. (Stock Titan)
  • Fennec Pharmaceuticals (NasdaqCM:FENC) Stock Forecast & Analyst Predictions (Simply Wall Street)

Follow FENC in your daily brief

Each trading day at 5 PM ET we post what happened to Fennec Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow FENC

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Fennec Pharmaceuticals stock

What does Fennec Pharmaceuticals do?

Fennec Pharmaceuticals trades on the Nasdaq under the ticker FENC. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 375 million dollars.

What is the ticker symbol for Fennec Pharmaceuticals?

Fennec Pharmaceuticals trades under the ticker FENC on the Nasdaq.

What is Fennec Pharmaceuticals's market cap?

Fennec Pharmaceuticals is a small cap stock with a market cap of about 375 million dollars.

How does Fennec Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves FENC stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow FENC stock every day?

Add FENC to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow FENC daily

A free brief on Fennec Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare FENC: FENC vs ARGX, FENC vs RVMD, FENC vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed